Prevention and treatment of alzheimer's disease

The use of biliary acid intestinal recapture inhibitors for preventing and treating Alzheimer's disease, optionally combined with a HMG-CoA reductase inhibitor, a cholesterol capture inhibitor, a cholesterol synthesis capture inhibitor or an APP secretase inhibitor.

Saved in:
Bibliographic Details
Main Authors CANTON, THIERRY, HEUER, HUBERT, PRADIER, LAURENT, SCHAFER, HANS-LUDWIG, BENAVIDES, JESUS
Format Patent
LanguageEnglish
Published 30.04.2008
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The use of biliary acid intestinal recapture inhibitors for preventing and treating Alzheimer's disease, optionally combined with a HMG-CoA reductase inhibitor, a cholesterol capture inhibitor, a cholesterol synthesis capture inhibitor or an APP secretase inhibitor.
Bibliography:Application Number: NZ20030540496